Intracellular Th
Price & Volume
Stats
See more52W Range | $62.78-$128 |
Market Cap | $13.4B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $613.7M |
Revenue Growth (YoY) | 39% |
Gross Profit (12 Mos) | $349.8M |
Diluted EPS | -$0.87 |
News
See moreYahoo Finance • 14 hours ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, HEES, SSTK on Behalf of Shareholders
Yahoo Finance • 4 months ago
Intra-Cellular Therapies (NASDAQ:ITCI) delivers shareholders fantastic 54% CAGR over 5 years, surging 3.9% in the last week alone
Yahoo Finance • 7 months ago
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Yahoo Finance • 11 months ago
Intra-Cellular Therapies, Inc.'s (NASDAQ:ITCI) Path To Profitability
About
CEO | Dr. Sharon Mates Ph.D. |
CFO | Mr. Sanjeev Narula |
Address | 430 East 29th Street, New York, NY, United States, 10016 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 610 |
